However, DPL with uterine leiomyomas has a low risk potential for malignant transformation, whereas DPL without exposure to estrogen, without uterine leiomyomas, and without ER and PgR expression may have a high malignant potential [7]. The gene discussed is ESR1; the disease is uterine corpus leiomyoma.